Migraine in Poland - a Web-based Cross-sectional Survey

Study Overview
=================
Brief Summary
-----------------
A survey of Polish respondents will aim to define migraine characteristics in Polish subjects. To achieve this, a structured questionnaire based mainly on American Migraine Prevalence and Prevention Study has been prepared to serve as a tool for data extraction. The obtained data should allow for defining disease parameters, burden and received treatments. Additionally questions regarding patients rhinological symptoms and COVID-19-related history were included.

Official Title
-----------------
Migraine in Poland - a Web-based Cross-sectional Survey

Conditions
-----------------
Migraine

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: consent to participate in the study Exclusion Criteria: responses missing in questionnaire

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Study Plan
=================
How is the study designed?
-----------------
What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Headache phenotype | Classification of reported headache according to International Classification of Headache Disorders | in the preceding year | 
| Migraine burden | Consequences of the disease measured by the Migraine Disability Assessment Test | in the preceding year | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Monthly headache days | Number of days per month | in the preceding month | 
| Monthly headache days | Number of days per year | in the preceding year | 
| Time from last headache professional consultation | Number of months | in the preceding 10 years | 
| Migraine diagnosed by headache professional | yes/no | in the preceding 10 years | 
| Age at diagnosis | years | from the onset of headache (time frame up to 99 years) | 
| Comoribidities | Disease according to International Classsification of Disease 10 | in the preceding year | 
| Type of previous headache professional consultation | Name of headache profession/speciality | in the preceding 10 years | 
| Number of consultations in the last year | Number 0-100 | in the last 12 months | 
| Number of consultations in the last year because of headaches | Number 0-100 | in the last 12 months | 
| Number of days spent in hospital in the last year because of headaches | Number 0-100 | in the last 12 months | 
| Acute treatment used | Name of abortive medication | in the preceding 10 years | 
| Preventive treatment used | Name of abortive medication | in the preceding 10 years | 
| Acute treatment frequency | Number of days per month | in the last 3 months | 
| Preventive treatment frequency | Number of months form the last dose | in the last 12 months | 
| Preventive treatment effectiveness | Likert scale | in the last 12 months | 
| Employment | Type of employment | in the last 12 months | 
| Time spent at work | Number of hours per week | in the last 12 months | 
| Work absence due to headache | Number of days per month | in the last month | 
| Presenteeism | Number of days per month | in the last month | 
| PHQ-9 Patient Health Questionnaire | Number | in the last 2 weeks | 
| Sinus headache | Number of days | in the last 3 months | 
| Sinonasal symptoms accompanying headache | Type of symptoms | in the last 12 months | 
| Sinonasal symptoms not associated with headache | Type of symptom | in the last 12 months | 
| COVID-19 association with headache | Likert scale | in the last 2 years | 
| COVID-19 vaccine association with headache | Likert scale | in the last year | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
migraine, headache, rhinosinusitis, COVID-19